Development of lipid nanoparticles for transdermal loteprednol etabonate delivery
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Microencapsulation"
DOI: 10.1080/02652048.2022.2079744
Abstract: Abstract Aim Loteprednol etabonate (LE) is a new generation corticosteroid that is used for the treatment of inflammatory and allergic conditions of the eye. Therefore, solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) were… read more here.
Keywords: lipid nanoparticles; nanoparticles transdermal; sln nlc; development lipid ... See more keywords